Total Payments
$5,072
2024 Payments
$674.13
Companies
36
Transactions
265
Medicare Patients
2,666
Medicare Billing
$943,308
Payment Breakdown by Category
Food & Beverage$4,923 (97.1%)
Education$149.18 (2.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,923 | 257 | 97.1% |
| Education | $149.18 | 8 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $491.20 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $458.46 | 29 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $420.11 | 23 | $0 (2024) |
| NxStage Medical, Inc. | $395.01 | 6 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $329.90 | 19 | $0 (2024) |
| Horizon Therapeutics plc | $324.95 | 17 | $0 (2023) |
| AKEBIA THERAPEUTICS INC | $253.71 | 16 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $243.92 | 14 | $0 (2024) |
| Relypsa, Inc. | $218.56 | 13 | $0 (2020) |
| CALLIDITAS THERAPEUTICS US INC. | $213.76 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $674.13 | 33 | Amgen Inc. ($214.21) |
| 2023 | $733.68 | 35 | Travere Therapeutics, Inc. ($85.09) |
| 2022 | $1,120 | 57 | Fresenius USA Marketing, Inc. ($168.35) |
| 2021 | $406.59 | 23 | Fresenius USA Marketing, Inc. ($72.03) |
| 2020 | $290.22 | 17 | AKEBIA THERAPEUTICS INC ($85.90) |
| 2019 | $722.94 | 46 | Relypsa, Inc. ($139.71) |
| 2018 | $484.52 | 26 | NxStage Medical, Inc. ($66.59) |
| 2017 | $640.07 | 28 | NxStage Medical, Inc. ($328.42) |
All Payment Transactions
265 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Nephrology | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Genetic Disease | ||||||
| 10/18/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Nephrology | ||||||
| 10/17/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/15/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Rare Disease | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Nephrology | ||||||
| 09/20/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Nephrology | ||||||
| 09/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Inflammation | ||||||
| 09/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/06/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: NEPHROLOGY | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/05/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Obesity | ||||||
| 07/19/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.03 | General |
| 07/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Cardio-renal | ||||||
| 06/11/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/24/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $31.12 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 472 | 1,164 | $430,901 | $175,634 |
| 2022 | 10 | 606 | 1,491 | $528,818 | $223,216 |
| 2021 | 11 | 756 | 1,982 | $662,349 | $287,573 |
| 2020 | 14 | 832 | 2,003 | $693,199 | $256,885 |
Total Patients
2,666
Total Services
6,640
Medicare Billing
$943,308
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 59 | 408 | $257,040 | $107,202 | 41.7% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 29 | 142 | $74,550 | $30,062 | 40.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 113 | 205 | $25,625 | $12,249 | 47.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 209 | $35,250 | $11,670 | 33.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 54 | 89 | $13,350 | $4,691 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $6,240 | $3,013 | 48.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 28 | $4,900 | $2,533 | 51.7% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 20 | 38 | $9,196 | $2,337 | 25.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $4,750 | $1,877 | 39.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 58 | 426 | $268,380 | $114,309 | 42.6% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 34 | 204 | $107,100 | $45,246 | 42.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 88 | 176 | $30,800 | $13,202 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 203 | $30,850 | $13,046 | 42.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 107 | 182 | $22,750 | $9,818 | 43.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 85 | 142 | $21,300 | $7,880 | 37.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 18 | 32 | $16,800 | $7,157 | 42.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $7,270 | $4,627 | 63.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 30 | $10,500 | $4,415 | 42.0% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 23 | 54 | $13,068 | $3,516 | 26.9% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 63 | 512 | $322,560 | $139,732 | 43.3% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 36 | 242 | $127,050 | $53,828 | 42.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 152 | 307 | $53,725 | $24,563 | 45.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 146 | 311 | $38,875 | $17,317 | 44.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 103 | 176 | $26,850 | $15,327 | 57.1% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 125 | 235 | $35,250 | $13,370 | 37.9% |
About Dr. Michael Oliverio, M.D
Dr. Michael Oliverio, M.D is a Nephrology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497781314.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Oliverio, M.D has received a total of $5,072 in payments from pharmaceutical and medical device companies, with $674.13 received in 2024. These payments were reported across 265 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($4,923).
As a Medicare-enrolled provider, Oliverio has provided services to 2,666 Medicare beneficiaries, totaling 6,640 services with total Medicare billing of $943,308. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Raleigh, NC
- Active Since 06/23/2006
- Last Updated 09/11/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1497781314
Products in Payments
- KRYSTEXXA (Biological) $450.26
- System One (Device) $395.01
- JYNARQUE (Drug) $358.82
- Velphoro (Drug) $352.26
- Veltassa (Drug) $310.67
- ACTHAR (Biological) $286.37
- TARPEYO (Drug) $213.76
- Kerendia (Drug) $189.61
- AURYXIA (Drug) $180.48
- FARXIGA (Drug) $174.13
- Auryxia (Drug) $161.98
- LOKELMA (Drug) $155.77
- ULTOMIRIS (Biological) $111.72
- LUPKYNIS (Drug) $108.92
- Parsabiv (Drug) $105.25
- Parsabiv (Biological) $104.44
- SAMSCA (Drug) $99.64
- RAYALDEE (Drug) $97.07
- SOLIRIS (Drug) $78.33
- BENLYSTA (Biological) $74.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Raleigh
Jeffrey Hoggard, M.d, M.D
Nephrology — Payments: $100,306
Nephrology $100,306
Dr. Sammy Moghazi, M.d, M.D
Nephrology — Payments: $55,439
Nephrology $55,439
Dr. Libbie Mckenzie, Md, MD
Nephrology — Payments: $34,174
Nephrology $34,174
Karn Gupta, Md, MD
Nephrology — Payments: $11,108
Nephrology $11,108
Dr. Michael Casey, M.d, M.D
Nephrology — Payments: $8,023
Nephrology $8,023
Dr. Phillip Timmons, M.d, M.D
Nephrology — Payments: $6,018
Nephrology $6,018